JPRN-UMIN000021981
Completed
未知
Prognostic evaluation with focus on renal function of molecular target drugs for Unresectable or Metastatic Renal Cell Carcinoma patients with Renal Dysfunction - Prognostic evaluation with focus on renal function of molecular target drugs for Unresectable or Metastatic Renal Cell Carcinoma patients with Renal Dysfunction
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shinshu University school of medicine
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Presence or past history of interstitial pneumonia or pulmonary fibrosis or possible (2\)Active infections(excluding viral hepatitis) (3\)Severe cardiac disorder, renal disorder, liver disorder, ulcer with bleeding, intestinal tract paralysis, uncontrollable diabetes mellitus (4\)Presence of pleural effusion or ascites requiring drainage (5\)Presence of metastasis in central nerve system (6\)Active double cancer except carcinoma in situ or intramucosal cancer(synchronous double or asynchronous double cancer with disease free duration to be within 3 years) (7\)Pregnant females or nursing mothers who can not stop lactation.Patients or partners, who do not attempt to doing contraception during the study period. (8\)Severe mental disorder (9\)Severe drug hypersensitivity (10\)As determined by the principal investigator or the sub\-investigator the subject is not adequate to participate in the trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prospective evaluation of renal function and proteinuria in chronic kidney disease patientsProteinuriaJPRN-UMIN000007371Aichi welfare agricultural cooperative association Anjo Kosei Hospital60
Completed
Not Applicable
rinary neutrophil gelatinase-associated lipocalin(NGAL) excretion and Renal Functions in Mild Maternal HydronephrosisMild Maternal Hydronephrosis in PregnancyRenal and Urogenital - Kidney diseaseReproductive Health and Childbirth - Fetal medicine and complications of pregnancyACTRN12614000455662Emre Goksan Pabuccu86
Recruiting
Not Applicable
Clinical study of long-term prognosis of renal function after contrast media used examination and treatment (enhanced CT and angiography)chronic kidney diseaseJPRN-UMIN000015307Shonan Kamakura General Hospital1,080
Active, not recruiting
Phase 1
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2014-005033-31-FRAddmedica S.A.S
Recruiting
Not Applicable
Prospective study of prognostic markers of kidney damage in cardiorenal syndromeChronic kidney disease in cardiorenal syndromeN18Chronic kidney diseaseDRKS00026098niversitätsmedizin Göttingen170